Allergy, parasites, and the hygiene hypothesis M Yazdanbakhsh, PG Kremsner, R Van Ree Science 296 (5567), 490-494, 2002 | 1962 | 2002 |
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children RTS, S Clinical Trials Partnership New England Journal of Medicine 365 (20), 1863-1875, 2011 | 918 | 2011 |
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10 AHJ van den Biggelaar, R van Ree, LC Rodrigues, B Lell, AM Deelder, ... The Lancet 356 (9243), 1723-1727, 2000 | 888 | 2000 |
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts The Lancet 386 (9988), 31-45, 2015 | 832 | 2015 |
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants U D'Alessandro | 760* | 2012 |
Artesunate combinations for treatment of malaria: meta-analysis International Artemisinin Study Group The Lancet 363 (9402), 9-17, 2004 | 700 | 2004 |
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms D Ménard, N Khim, J Beghain, AA Adegnika, M Shafiul-Alam, O Amodu, ... New England Journal of Medicine 374 (25), 2453-2464, 2016 | 486 | 2016 |
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 446 | 2016 |
Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren AHJ van den Biggelaar, LC Rodrigues, R van Ree, JS van der Zee, ... Journal of Infectious Diseases 189 (5), 892-900, 2004 | 442 | 2004 |
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma B McCloskey, A Zumla, G Ippolito, L Blumberg, P Arbon, A Cicero, ... The Lancet 395 (10230), 1096-1099, 2020 | 416 | 2020 |
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial M Adjuik, P Agnamey, A Babiker, S Borrmann, P Brasseur, M Cisse, ... The Lancet 359 (9315), 1365-1372, 2002 | 399 | 2002 |
Antimalarial combinations PG Kremsner, S Krishna The Lancet 364 (9430), 285-294, 2004 | 375 | 2004 |
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 360 | 2015 |
A research agenda for malaria eradication: vector control malERA Consultative Group on Vector Control PLoS medicine 8 (1), e1000401, 2011 | 358* | 2011 |
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 357 | 2017 |
Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children AJF Luty, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, B Greve, ... The Journal of infectious diseases 179 (4), 980-988, 1999 | 319 | 1999 |
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses DJ Conway, DR Cavanagh, K Tanabe, C Roper, ZS Mikes, N Sakihama, ... Nature medicine 6 (6), 689-692, 2000 | 316 | 2000 |
Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria AJF Luty, DJ Perkins, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, ... Infection and immunity 68 (7), 3909-3915, 2000 | 301 | 2000 |
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. RTS. S Clinical Trials Partnership PLoS medicine 11 (7), e1001685, 2014 | 300 | 2014 |
Comparison of methods for the rapid laboratory assessment of children with malaria. T Planche, S Krishna, M Kombila, K Engel, JF Faucher, E Ngou-Milama, ... The American journal of tropical medicine and hygiene 65 (5), 599-602, 2001 | 295 | 2001 |